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Access Adherence to Antiretroviral Therapy. A community-based 
antiretroviral (ART) drugs adherence study was conducted in Kolkata, India 
beginning in January and concluding in March 2011. This study was 
designed to explore the level of adherence as well as factors influencing 
adherence to ART by those who are receiving treatment through a public 
health care delivery system. This health care system is implemented through 
the National AIDS Control Program in the state of West Bengal, India. The 
research findings showed a high degree of non-adherence, between 48-52%, 
among the ART recipients. The analysis highlights a number of key factors 
negatively influencing adherence including long waiting time at the ART 
center, distance from residence to ART Centre, travel related expenditure, 
and fear of being identified as HIV + to family members and neighbors. 
Some positive influences were identified in the data as well. If a person is a 
member of a positive people network there is a greater chance for adherence 
as well as if an individual self-identifies as positive to others. However, no 
single factor, rather a combination of several factors, proved to be responsible 
for influencing ART adherence among recipients.    
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1.  Introduction 
 
Regular intake of antiretrovirals in scheduled doses is shown to bring down the positive person’s ‘Viral Load’ as 
well as boost immunity through an increase in the CD4 Count. This helps avert opportunistic diseases and other 
infections while improving the quality of life for people living with HIV/AIDS (PLHIV). The role of ART is to 
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suppress the multiplication of viruses for which regular and continued treatment is essential. ART does not cure the 
illness but helps the incumbent individual lead a normal life as ART delays the onset of severe illness through the 
suppression of the virus. Significant reduction of viral load in a patient’s circulation makes the individual 
noninfective. As a result, HIV positive individuals taking ARTs will not be able to transmit the infection to others. 
This helps with prevention and is commonly known as ‘Treatment as Prevention’ (TasP). In India, as part of the 
National Strategy, ‘Treatment as Prevention’ is considered an important element of the HIV Prevention program. 
However poor adherence to ART shall not protect the individual from getting opportunistic diseases and other 
infections. Non-adherence to ART could be a prime reason behind the development of resistant strains. A 
combination of anti-retroviral drugs is the treatment of choice. To ensure success in ART regimens requires a strong 
commitment on the part of the patient to continue with the treatment regime. 
Non-adherence to ART remains a concern across the world and is recognized as the most important contributing 
factor behind treatment failure and the development of a resistant strain. To ensure effectiveness, patients need to 
take the prescribed drugs on time, with proper dosages and scheduling. It is hard to achieve 100% medication 
adherence, but studies have shown that if adherence level is maintained to the tune of 70% to 90% this could bring 
about effective outcomes of ART intervention. It has also been demonstrated that a 10% higher level of adherence 
results in 21% reduction in disease progression provided  
‘Medication adherence’ is good.   
There is no substantive information regarding the percentage of treatment failure due to development of a 
resistant strain in India. ART delivery centers, in general, do not possess laboratory support systems to confirm viral 
suppression which is often assessed through the clinical progression of the disease. Diagnosis of treatment failure 
due to a mutated HIV strain often is delayed, the clinician has to rely primarily on the drop of CD4 count and 
deterioration of overall patient health. There is a high probability of HIV transmission from individuals, who are 
experiencing treatment failure as the recipients often believe that they are not going to transmit HIV infection 
through unprotected sex or through other possible means as they are under the treatment regime. However, one of the 
critical prerequisites for successful ART depends on a high level of adherence by the recipient to the prescribed 
medicine. In absence of sophisticated laboratory support to assess adherence to ART in the country, this study was 
designed to measure adherence to ART using a pretested tool to collect the responses from participants.    
The objective of the Study In view of the lack of data surrounding ART adherence among those is receiving 
treatment with antiretroviral medications. The researchers from School of Tropical Medicine jointly with DMSC 
developed a plan to implement a study on ART adherence among recipients in Kolkata, India. The objectives of this 
study were to assess adherence to ART among those who are receiving treatment, to identify factors that might affect 
ARTs’ adherence among the recipients categorized under personal, familial, social and structural factors, and also to 
find out possible mechanisms and approaches that may aid in improving ART adherence.   
 
2.  Research Methods 
 
Community through positive peoples’ networks in the state of West Bengal. All samples were drawn from ART 
recipients who are linked to one or other positive networks but not necessarily members of the network. Information 
was gathered from networks to ensure reach and accessibility of the participants. The researchers decided not to 
involve ‘service providers’ of the ART centers or the staff members of the service delivery institutes to avoid any 
possible ‘bias’ and to reduce ‘social desirability responses’ from the participants.   
Participants who agreed to take part in the study were taken as part of a valid sample for the proposed study. An 
Instrument was developed to collect relevant socio-demographic characteristics, health-seeking behaviors including 
sexual behavior and practices, state of health, knowledge, and awareness on HIV and AIDS including risk perception 
among PLHIV who are on ART. The questionnaire was pretested among ART recipients before finalization. 
Information was collected on stigma and discrimination that might have affected their accessibility and utilization of 
ART services. Data were analyzed to look at plausible relationships between drug adherence and all other socio-
structural parameters.   
Adherence to ART was recorded as taking medications as prescribed by the physician at the correct time and the 
correct doses during three time periods: last week, last month and the last six months. Missing of one or more doses 
during last month is defined as an operational definition of non-adherence to treatment. Interviews were carried out 
in the field preceded by taking the informed consent, from the participants. All participants were given a full 
understanding of the importance of the study and their rights not to participate and to withdraw if they decide at any 
point.  
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Four positive individuals were recruited as field investigators to carry out the study. After taking informed 
consent from the individuals, the investigators explained the objective of the study in detail to the interviewees prior 
to the introduction of the questionnaire. All filled in questionnaires were checked by the field supervisor to identify 
gaps or inconsistencies in the responses. The data was then entered and analyzed using Epi-info package.   
 
3.  Results and Analysis 
 
Socio-economic background  
 
Out of the 113 individuals interviewed, the maximum, 23%, was between 30 to 34 years, followed by 17.7% in 
35 to 39 years and 40 to 44 years (Table 1). Out of the total, 63.7% were female (Table 2) and 90.3% were married. 
Out of all interviewed 62.8% were literate (Table 3). Out of the 113, 52.2% were from the sex worker community 
while the remaining 47.8% were comprised of various employment backgrounds (Table 4).    
 
Adherence 
 
Based on the operational definition used in the study, only 42.5% of the sample was found compliant with ART 
treatment. Reasons put forward for non-compliance to ART include side effects of medicine, distance from residence 
to ART Centre (Table 5), lack of social support, fear to be identified as positive followed by possible social 
discrimination. A large percentage of ART recipients (22.1%) shared a difficulty in reaching the ART center as the 
major reason for not collecting medicines regularly. Cost of traveling expenses was identified as one of the 
prominent demotivating factors. Out of all participants, around 62.8% of them received some kind of support from 
their family members whereas the remaining 37.2% did not receive supports financially, material or any other social 
or moral support. Of those who took part in the study, the majority of those who are (71.4%) non-compliant to ART 
were between the ages of 18 – 24 followed by 35 – 39 year age group (70%). It was found that people from other 
occupational backgrounds were more (66.7%) non-compliant to their ART regimen when compared to sex workers 
(49.2%). Non-compliance to ART was found to be more prevalent among those who concealed their positive identity 
to their family members and or to their neighbors (Table 6).     
Those who had symptoms related to side effects of the medicine were less compliant (67.1%) than those (37.8%) 
who had not suffered from any side effects (Table 7). Those who are active members of a positive people network 
are more compliant than others (Table 8). Those who do not receive family support are more (59.5%) non-compliant 
to ART (Table 9). It was also observed that 90% of participants, who have no adequate knowledge regarding 
consequences of discontinuation of medicine, are more non-compliant to medicine (Table 10) as opposed to those 
who had adequate knowledge of discontinuation (50.5%). Out of the 113 participants, it was revealed that those who 
pay more than Rs. 80/-per day as travel expenses is less non-compliant (64.3%) to ART in comparison to those who 
paid less or nominal sum of money to attend ART Centre (36.4%)(Table 11). Waiting period at the clinic was found 
to also influence ART adherence. Those who had to wait a shorter period of time (less than 30 minutes) at the ART 
Centre were more (58.8%) compliant to ART compared to those who had to wait longer than 30 minutes to collect 
medicine (37.5%).   
The frequency of non-adherence was more prevalent among participants who are literate compared to those who 
are illiterate. It was encouraging to note that within the study population those who are members of positive peoples’ 
network showed better compliance with antiretroviral drugs as compared to nonmembers.    
Multivariate analysis was done taking into account five major determinants of adherence namely long waiting 
time at the service outlets, expenses related to travel, attitude and practices of the health care providers (Table 12), 
distance from residence to ART Centre (Table 13) and those who had suffered from side effects of the medicine.   
While carrying out multivariate analysis it was observed that there is no single factor which has more 
contribution in influencing ART adherence over the others. So it could be concluded that the poor adherence to ART 
can be attributed to a combination of factors as mentioned above. 
   
Discussion 
 
The World Health Organization (WHO) recommends that accurate assessment of adherence is necessary for 
effective and efficient treatment planning viii,ix. Decisions to make a change in the treatment regimen, and to 
promote adherence depends on the valid and reliable measurement of adherence and reasons behind the failure to 
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adhere. Without formal assessment, providers are unlikely to assess and identify the level of adherence (and non-
adherence) thereby missing the opportunity for reinforcement of the message and possible usage of constructive 
interventions. If adherence is below optimal levels blood levels of ART recipients would be low and HIV virus will 
continue to replicate. Our study showed that adherence among the ART recipients is as low as 48%. With this level 
of adherence, it is highly unlikely that the virus load will come down at a level that would help the improvement of 
health status and prevention of opportunistic infection among the ART recipients and will not make him/her 
noninfective. HIV is highly adaptive to viral-suppressing pressures and can rapidly mutate to develop resistance X, 
xii. In some cases, ART may still improve CD4 cell count despite ongoing viral replication due to development of 
mutant viruses which emerge less fit and less destructive than the wild-type of HIV strain xiii.    
Complete viral suppression is defined as less than 40 HIV copies/ml of blood xiv. Failure to sustain complete 
viral suppression is a precursor for the development of HIV mutation followed by treatment failures leading to 
progression of the disease.  Moreover, development of resistance against the first line of treatment reduces physician 
choices leaving behind only the more costly options to start with a second or third line of the ART treatment.   
Transmission of HIV including the mutated strain through the exchange of body fluid will create major public 
health problems in addition to increasing the burden of heightened expenditure.  
Studies have established that up to 95% adherence is necessary for HIV viral suppression xvi, xvii. Studies have 
linked the relationship between adherence and viral load (VL), as adherence decreased xviii VLs increase sharply in 
a dose-response effect and it is possible to conclude that greater adherence levels are associated with greater 
reduction in VLs xix,  xx. Accurate and reliable measures of adherence and a better understanding of both barriers 
and facilitators of adherence are needed to help clinicians identify patients who need additional assistance with their 
pill taking, to design and evaluate effective interventions to enhance adherence, and to interpret the role of adherence 
in evaluating clinical outcomes and making treatment decisions, xxii. Our research shows that major barriers to ART 
adherence are long waiting time, distance from the house to ART Centre, the burden of traveling expense and fear of 
discrimination and behavior of staff at the ART centers.   
In order to identify adherence-related issues and challenges (irrespective of which class of ART patients is on) 
and to develop appropriate interventions, adherence measurement is fundamental and tools need to be developed to 
assess adherence xxiii, xxiv, xxv. In India, at present there are more than 500,000 cases registered under ART having 
no mechanism in place for the systematic collection of data or analysis of ART uptake and adherence there is an 
urgent need to probe into these issues with an objective to find out possible gaps and challenges. Our findings 
suggest that reasons behind non-compliance to ART are many and multiple in nature as observed in other studies 
xxvi, xxvii. Various familial, social and structural factors affect regular intake of ART at the individual level. It is of 
paramount importance to address those underlying factors so as to improve the quality of life of positive people 
through influencing their ART adherence behavior and practices xxviii, xxix, xxx, xxxi.    
 
4.  Conclusion 
 
It is assumed that multiple stakeholders at various levels influence ART adherence. Without undermining the role 
of service providers in improving ART adherence one needs to look into a gamut of socioeconomic and cultural 
factors as observed in our findings xxxii, xxxiii, xxxiv. In India, ARTs are made available and accessible to all those 
who need it and are provided free of cost. However poor compliance to ART is likely to diminish the effectiveness of 
any national program on care and treatment xxxv. The outcome of this study can help in designing a better 
framework of service delivery program to improve ART adherence, which in turn would help improve the quality of 
life for positive peoples while preventing the occurrence of a resistant strain. Ensuring adherence would also help 
prevention programs as the infected individuals who are receiving ART regularly will be noninfective and unable to 
transmit infection.  
The efficacies of the current antiretroviral drugs are extremely good. Therefore, the most important factor for 
virological control depends on the high degree of adherence. From the public health point of view, the significance 
of transmission of HIV from the infected individual to others would be nil or significantly less, provided the infected 
individual adheres to ART. These could be a huge waste of national resources provided the objective of ART failed 
to bring about the desired outcome in the life of the individuals due to poor adherence leading to the development of 
a resistant strain. This would force the physician to prescribe more costly ‘second’ or ‘third’ lines of ART regimen.    
The following recommendations have emerged from the study. There is a need to develop an effective 
mechanism to monitor ART adherence at each ART Centres followed by analysis and interpretation of data. This 
would help to provide requisite feedback to physician and to develop a system to improve adherence to ART. A 
IRJEIS           ISSN: 2454-2261    
Jana, S., Ray, P., Roy, K., & Mandal, D. (2015). A society based research to assess adherence of antiretroviral 
therapy. International Research Journal of Engineering, IT & Scientific Research, 1(1), 1-11. 
https://sloap.org/journals/index.php/irjeis/article/view/233 
5 
system should be in place to support of HIV positive patients by linking them with HIV support groups and 
networks. More social and clinical support services have to be organized closer to the residences of the positive HIV 
people. This could be made possible through routing delivery of services through community-based organizations 
and positive people networks. Early identification of side effects and a user-friendly system of management needs to 
be developed and delivered at the earliest opportunity. The ART centers should review their patient flow system and 
bring down the waiting time for patients who attend clinics.    
ART adherence is a big challenge, there is no shortcut procedure to improve adherence among the ART 
recipients. It requires effective communication with the patients, aided with adequate social support, and 
encouragement to the positives. All other factors identified in the study linked stigma and discrimination. This has to 
be addressed through an introduction of a system for reporting cases of discrimination, followed by counseling and 
training of the service providers with provisions for compensation to those discriminated against.    
 
 
Table 1 
ART compliance among people of different age group 
   
ART Compliance       Age Group       Total      
  18 – 24   25 – 29   30 – 34    
  50 and above    
35 – 39   40 – 44   45  –  49  
No   Count  5   8   10   14   12   9   7   65      
   % within age group (in years)   71.4   
  63.6   57.5   
53.3   38.5   70.0   60.0   64.3    
Yes   Count  2   7   16   6   8   5   4   48      
   % within age group (in years)   28.6   
  36.4   42.5   
46.7   61.5   30.0   40.0   35.7    
Total  Count  7   15   26   20   20   14   11   113     
   % within age group (in years)   100   100   100   100   100   100   100  
  100   
   
Out of the 113 interviewees, the maximum (71.4%) non-compliant found was in the age group of 18 – 24 years 
followed by those in the age group of 35 – 39 years.    
   
      
Table 2 
ART compliance among genders 
   
Gender   Compliant   Non-compliant   
Male 11 (26.8%)   30 (73.2%)   
Female   37 (51.4%)   35 (48.6%)   
Out of the 113 interviewees, it was found that males were more (73.2%) non-compliant to ART compared to 
females (48.6%)   
   
   
Table 3 
ART Compliance among people of different educational status 
   
ART Compliance   Educational Status   Total   
  Illiterate   Literate     
No   Count 18   47   65   
   % within Educational status 42.9   66.2   57.5   
Yes   Count 24   24   48   
   % within Educational status 57.1   33.8   42.5   
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Total Count 42   71   113   
   % within Educational status 100   100   100   
   
Out of the 113 interviewees, it was found that educated individuals are more (66.2%) noncompliant to ART 
compared to illiterates (42.9%)   
   
   
Table 4 
ART compliance among people of different occupation 
   
ART Compliance   Occupation   Total   
  All other occupation in combination Sex Worker    
No   Count 36   29   65   
   % within occupation  66.7   
Yes   Count  18   30   48   
49.2   57.5   
   % within occupation  33.3   
Total  Count  54   59   113   
50.8   42.5   
   % within occupation  100   100   100   
   
Out of the 113 interviewees, it was found that people from all other occupation in combination are more (66.7%) 
non-compliant to ART compared to sex workers (49.2%)   
   
   
Table 5 
ART compliance among people who has difficulty in reaching the center 
   
ART Compliance   Difficult to reach centre   Total   
  No   Yes     
No   Count  52   13   65   
 
   % within difficult to reach centre   
Yes   Count  36   12   48   
59.1   52.0   57.5   
   % within difficult to reach centre   
Total  Count  88   25   113   
40.9   48.0   42.5   
   % within difficult to reach centre   100   100   100   
   
Out of the 113 interviewees, who find difficulty in reaching to the center are in fact less (52.0%) non-compliant 
to ART compared to those who do not find it difficult to reach to the ART Centre (59.1%)   
   
Table 6 
ART compliance among people whose neighbor knows the result 
   
ART Compliance   Neighbor knows your positive status Total   
  No   Yes     
No   Count 49   16   65   
 % within neighbor knows your positive status   57.6   57.1   57.5   
Yes   Count 36   12   48   
   % within neighbor knows your positive status   42.4   42.9   42.5   
Total Count 85   28   113   
   % within neighbor knows your positive status   100   100   100   
   
Out of the 113 interviewees, it was found that non-compliance was more than 50% whether their positive status 
was known to the neighbor or not   
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Table 7 
ART Compliance among people who feels side effects to take medicine 
   
ART Compliance   Feel any side effects to take medicine    Total   
  No   Yes       
No   Count  14   51   65     
   % who has not suffered from any side effects to take medicine   37.8   67.1  
  57.5     
Yes   Count  23   25   48     
   % who has not suffered from any side effects to take medicine   62.2   32.9  
  42.5     
Total Count 37   76   113   
   
   % who has not suffered from any side effects to take medicine   100   100   100   
  Out of the 113 interviewees, it was found that those who had suffered from any side effects were more non-
compliant (67.1%) to ART compared to 37.8% of them who were having no side effects   
   
Table 8 
ART compliance among people who are a member of various networks 
   
ART Compliance     Member of     Total   
  None  Mamata Network   Krishnanagar Network   
No   Count  14   32   10   9   65   
   % within member of  63.6   52.5   83.3   50.0   57.5   
Yes   Count  8   29   2   9   48   
   % within member of  36.4   47.5   16.7   50.0   42.5   
Total  Count  22   61   12   18   113   
   % within member of  100.0  100.0  100.0  100.0  100   
Ranaghat Network     
   
Out of the 113 interviewees, it was found that those who were members of Ranaghat Network (50.0%) and 
Mamata Network (52.5%) were less non-compliant   
   
Table 9 
ART compliance among people who receive family support 
   
ART Compliance   Receive family support   Total   
  No   Yes     
No   Count 25   40   65   
   % within receive family support   
Yes   Count  17   31   48   
59.5   56.3   57.5   
   % within receive family support   
Total  Count  42   71   113   
40.5   43.7   42.5   
   % within receive family support   100   100   100   
   
Out of the 113 interviewees, it was found that those who do not receive family support were more (59.5%) non-
compliant to ART compared to those who received support (56.3%)   
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Table 10 
ART compliance among people who has knowledge about the effect of discontinuation of medicine 
   
ART Compliance   Knowledge about the effect of discontinuation of medicine   Total   
  No   Yes       
No   Count  18   47   65     
   % has knowledge about effect of discontinuation of medicine   90.0   50.5  
  57.5     
Yes   Count  2   46   48     
   % has knowledge about effect of discontinuation of medicine   10.0   49.5  
  42.5     
Total Count 20   93   113   
   % has knowledge about the effect of discontinuation of medicine   100   100   100   
   
Out of the 113 interviewees, it was found that those who had no knowledge about the effect of discontinuation of 
medicine were more (90.0%) non-compliant to ART compared to those who had knowledge about the effect of 
discontinuation (50.5%)   
   
 
Table 11 
ART compliance among people whose travel cost to reach ART Centre is expensive 
   
ART Compliance   Travelling Expense   
  No   Yes     
No   Count  4   9   13   
Total   
   % within Travelling Expense  36.4   
Yes   Count  7   5   12   
64.3   52.0   
   % within Travelling Expense  63.6   
Total  Count  11   14   25   
35.7   48.0   
   % within Travelling Expense  100   100   100   
   
Out of the 113 interviewees, it was found that those whose traveling expense was more were more (64.3%) non-
compliant to ART compared to those whose traveling expense was less  
(36.4%)   
 
Table 12 
ART compliance among people which depended on the behavior of health staff 
   
ART Compliance   Behavior of health staff   Total   
  No   Yes     
No   Count 13      13   
   % within Behavior of health staff   54.2      52.0   
Yes   Count 11   1   12   
   % within Behavior of health staff   45.8   100.0 48.0   
Total Count 24   1   25   
   % within Behavior of health 100   100   100   
   
   
Out of the interviewees, it was found that behavior of staffs did not have any effect on compliance   
   
 
 
IRJEIS           ISSN: 2454-2261    
Jana, S., Ray, P., Roy, K., & Mandal, D. (2015). A society based research to assess adherence of antiretroviral 
therapy. International Research Journal of Engineering, IT & Scientific Research, 1(1), 1-11. 
https://sloap.org/journals/index.php/irjeis/article/view/233 
9 
Table 13 
ART compliance among people whose house is far from ART Centre 
   
ART Compliance   Far from the house   Total   
  No   Yes     
No   Count 3   10   13   
   % far from the house  42.9   
Yes   Count  4   8   12   
55.6   52.0   
   % far from the house  57.1   
Total  Count  7   18   25   
44.4   48.0   
   % far from the house  100   100   100   
   
Out of the 113 interviewees, it was found that those whose house was further away from the ART Centre were 
more (55.6%) non-compliant to ART compared to those whose house was nearby (42.9%)   
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